/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Syed Numan

American Institute of Biological Sciences(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

18

Papers

94

Citations

3

h-index

3

i10-index

Syed Numan is an academic researcher from American Institute of Biological Sciences. The author has contributed to research in topics: Erythropoietin and Anemia Treatment & Biosimilars and Bioanalytical Methods & Pharmaceutical studies and practices. The author has an h-index of 3, co-authored 16 publications.

Research Topics

Erythropoietin and Anemia Treatment Biosimilars and Bioanalytical Methods Pharmaceutical studies and practices Tuberculosis Research and Epidemiology Iron Metabolism and Disorders

Papers by this author

works

Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System

2020 · Drug Safety · 29 citations

https://doi.org/10.1007/s40264-020-01022-2

Henry Trumbo K Kaluza Syed Numan Lawrence T. Goodnough

Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.6507722.v5

Syed Numan Freddy Faccin

Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.6507722.v2

Syed Numan Freddy Faccin

Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.6507722

Syed Numan Freddy Faccin

Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.6507722.v3

Syed Numan Freddy Faccin

Non-medical Switching From Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies

2018 · Figshare · 0 citations

https://doi.org/10.6084/m9.figshare.6507722.v4

Syed Numan Freddy Faccin

Research topics

topics

Erythropoietin and Anemia Treatment

Biosimilars and Bioanalytical Methods

Pharmaceutical studies and practices

Tuberculosis Research and Epidemiology

Iron Metabolism and Disorders

Chat about Author

Papers

Chat

Click to start Chat